Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Externally anchored fully covered metal stents with plastic stent versus uncovered metal stents for unresectable distal malignant biliary obstruction: a multicenter randomized trial.

Created on 17 Nov 2026

Authors

Jin Ho Choi, Junyeol Kim, Woo Hyun Paik, In Rae Cho, Ji Kon Ryu, Sung Yong Han, Seong-Hun Kim, Eaum Seok Lee, Sang Myung Woo, Min Kyu Jung, Joung-Ho Han, Eunae Cho, Joo Seong Kim, Dong-Won Ahn, Sang Hyub Lee

Published in

Endoscopy. Nov 16, 2026. Epub Nov 16, 2026.

Abstract

Self-expandable metal stents (SEMS) are commonly used to treat malignant biliary obstruction (MBO). External plastic stent anchoring for fully covered SEMS (FCSEMS-EPS) has shown potential to improve stent patency; however, randomized evidence comparing this strategy with uncovered SEMS (USEMS) is limited.
This multicenter trial was conducted at nine tertiary referral centers in South Korea. Patients were enrolled from October 2021 to February 2024 and followed for 12 months after stent placement. Those with unresectable distal MBO were randomly assigned (1:1) to receive either FCSEMS-EPS or USEMS. The primary outcome was biliary stent dysfunction. Time-to-event analyses were performed using time to stent dysfunction within a competing risk framework.
113 patients were enrolled, of whom 99 were included in the final analysis (FCSEMS-EPS 48; USEMS 51). Stent dysfunction occurred less frequently in the FCSEMS-EPS group compared with the USEMS group (27.1% vs. 49.0%; P = 0.04). The cumulative incidence of stent dysfunction at 6 months was lower in the FCSEMS-EPS group (21.1% vs. 29.8%; Gray's test, P = 0.03). In multivariable competing risk analysis, FCSEMS-EPS was independently associated with a lower risk of stent dysfunction (subdistribution hazard ratio 0.44, 95%CI 0.21-0.90; P = 0.03). Procedure-related adverse events and overall survival did not differ between groups.
FCSEMS-EPS significantly reduced stent dysfunction compared with USEMS without increasing adverse events, supporting its effectiveness and safety as long-term biliary drainage in unresectable MBO.

PMID:
43039341
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 14
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement